BIO-key International, Inc. (BKYI)
OTCMKTS · Delayed Price · Currency is USD
4.750
+0.090 (1.93%)
At close: Jun 24, 2026
BIO-key International Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6.63 | 5.94 | 6.93 | 7.75 | 7.02 | 5.11 | |
Revenue Growth (YoY) | 4.37% | -14.32% | -10.64% | 10.46% | 37.26% | 80.29% |
Cost of Revenue | 1.47 | 1.37 | 1.29 | 6.32 | 2.44 | 1.67 |
Gross Profit | 5.16 | 4.56 | 5.64 | 1.43 | 4.58 | 3.44 |
Selling, General & Admin | 6.27 | 6.28 | 7.14 | 7.86 | 9.36 | 6.03 |
Research & Development | 2.63 | 2.61 | 2.51 | 2.39 | 3.25 | 2.36 |
Operating Expenses | 8.9 | 8.89 | 9.65 | 10.26 | 12.62 | 8.38 |
Operating Income | -3.74 | -4.33 | -4.01 | -8.83 | -8.04 | -4.94 |
Interest Expense | -0.27 | -0.32 | -0.3 | -0.22 | -1.16 | -0.02 |
Interest & Investment Income | 0 | 0 | 0 | 0.01 | 0 | 0 |
Currency Exchange Gain (Loss) | - | - | -0.01 | -0.04 | - | -0.05 |
EBT Excluding Unusual Items | -4 | -4.64 | -4.32 | -9.07 | -9.19 | -5.01 |
Impairment of Goodwill | - | - | - | - | -2.39 | - |
Gain (Loss) on Sale of Investments | - | -2.5 | - | - | -0.45 | -0.06 |
Gain (Loss) on Sale of Assets | - | - | - | 0.02 | - | - |
Other Unusual Items | - | - | - | 0.4 | 0.1 | - |
Pretax Income | -4 | -7.14 | -4.32 | -8.66 | -11.93 | -5.07 |
Income Tax Expense | 0.02 | 0.02 | -0.02 | -0.13 | -0.02 | - |
Net Income | -4.02 | -7.16 | -4.3 | -8.52 | -11.91 | -5.07 |
Net Income to Common | -4.02 | -7.16 | -4.3 | -8.52 | -11.91 | -5.07 |
Shares Outstanding (Basic) | 1 | 1 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 1 | 1 | 0 | 0 | 0 | 0 |
Shares Change (YoY) | 187.90% | 222.74% | 267.63% | 28.26% | 0.91% | 65.75% |
EPS (Basic) | -4.93 | -10.77 | -20.88 | -152.10 | -272.65 | -117.03 |
EPS (Diluted) | -4.93 | -10.77 | -20.88 | -152.10 | -272.65 | -117.03 |
Free Cash Flow | - | -4.68 | -2.93 | -3.79 | -6.31 | -9.02 |
Free Cash Flow Per Share | - | -7.04 | -14.21 | -67.72 | -144.48 | -208.39 |
Gross Margin | 77.84% | 76.88% | 81.39% | 18.46% | 65.25% | 67.29% |
Operating Margin | -56.34% | -72.89% | -57.88% | -113.82% | -114.47% | -96.63% |
Profit Margin | -60.58% | -120.55% | -62.06% | -109.89% | -169.65% | -99.05% |
Free Cash Flow Margin | - | -78.83% | -42.24% | -48.93% | -89.90% | -176.37% |
EBITDA | -3.4 | -3.98 | -3.61 | -8.4 | -7.69 | -4.67 |
EBITDA Margin | -51.19% | -66.96% | -52.14% | -108.28% | -109.60% | -91.33% |
D&A For EBITDA | 0.34 | 0.35 | 0.4 | 0.43 | 0.34 | 0.27 |
EBIT | -3.74 | -4.33 | -4.01 | -8.83 | -8.04 | -4.94 |
EBIT Margin | -56.34% | -72.89% | -57.88% | -113.82% | -114.47% | -96.63% |
Revenue as Reported | 6.63 | 5.94 | 6.93 | 7.75 | 7.02 | - |
Advertising Expenses | - | 0.29 | 0.35 | 0.34 | 0.84 | 0.53 |